We're where the business of medicine gets answers. An independent news media organization covering biotech, pharma, science, policy, finance, venture capital and markets, and how they drive the life sciences industry. Read us at www.endpts.com.
Reporter @ Endpoints News
Covering biotech, pharma, AI, and more — the future of medicine
adunn@endpointsnews.com
Endpoints News executive editor -- where the business of medicine gets answers. Posts on biotech, pharma, drugs, financial markets science and business (and how they all intersect). #biosky
Priors: Bloomberg News + the Covid vaccine tracker. CQ.
reporting on the $, people & startups in the biotech world for Endpoints News | klahucik@endpointsnews.com | also coach high school XC + Track & Field team | askin Qs, joggin 26.2 | 🌎🏳️🌈🏃🏻♂️🗞️💨
reporting on drugs and biotechs @endpoints • email me: lwu@endpointsnews.com • Signal: leileiwu.24 • ✌️
Pharma reporter at Endpoints News | Past: Fierce Biotech and CBS News | mbayer@endpointsnews.com or maxbayer.10 on Signal. he/him
Reporting on pharma and biotech for Endpoints News. Baseball fan, Northwestern alum. Message me on Signal: maxgelman.37
deputy editor @endpts.com // formerly the verge & abc news // soccer posts
Reporter covering health tech for Endpoints News. Formerly Business Insider and Modern Healthcare. Charleston native, Clemson alum. Go Tigers!
Senior editor, Endpoints News
features editor @endpts.com / fall 2021 fellow
@ksjatmit.bsky.social
Writing (and editing) stories on rare disease medicine, diagnostics and China
Reach out privately on Signal: jaredwhitlock.73
Biopharma reporter at Endpoints News | nicole@endpointsnews.com
official Bluesky account (check username👆)
Bugs, feature requests, feedback: support@bsky.app
